The Anti-Müllerian hormone precursor (proAMH) is not converted to the receptor-competent form (AMHN,C) in the circulating blood of mice

Endocrinology

Volumn 157, Issue 4, 2016, Pages 1622-1629

  Pankhurst, Michael W ^a   Leathart, Brandi Lee A ^a   Batchelor, Nicola J ^a   McLennan, Ian S ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI MULLERIAN HORMONE N C; ANTI MULLERIAN HORMONE PRECURSOR; HORMONE PRECURSOR; IMMUNOGLOBULIN; MUELLERIAN INHIBITING FACTOR; UNCLASSIFIED DRUG; PROTEIN PRECURSOR; RECOMBINANT PROTEIN;

ADULT; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BLOOD; BLOOD BRAIN BARRIER; BLOOD SAMPLING; CEREBROSPINAL FLUID; CONTROLLED STUDY; ELIMINATION HALF-LIFE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SPACE; FEMALE; GONAD; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; HALF LIFE TIME; METABOLIC CLEARANCE RATE; METABOLISM; PROTEIN DEGRADATION; WESTERN BLOTTING;

ANIMALS; ANTI-MULLERIAN HORMONE; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GONADS; HALF-LIFE; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; MALE; METABOLIC CLEARANCE RATE; MICE; PROTEIN PRECURSORS; PROTEOLYSIS; RECOMBINANT PROTEINS;

EID: 84962905156     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1834     Document Type: Article

References (44)

1. Teixeira J, Maheswaran S, Donahoe PK. Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev. 2001;22:657-674.
2. Mendis-Handagama SM, Ariyaratne HB, Fecteau KA, Grizzle JM, Jayasundera NK. Comparison of testis structure, function and thyroid hormone levels in control c57bl/6 mice and anti-mullerian hormone over expressing mice. Histol Histopathol. 2010;25:901-908.
3. Salva A, Hardy MP, Wu XF, et al. Müllerian-inhibiting substance inhibits rat Leydig cell regeneration after ethylene dimethanesulphonate ablation. Biol Reprod. 2004;70:600-607.
4. Wang PY, Protheroe A, Clarkson AN, Imhoff F, Koishi K, McLennan IS. Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior. Proc Natl Acad Sci USA. 2009;106: 7203-7208.
5. Wang PY, Koishi K, McGeachie AB, et al. Mullerian inhibiting substance acts as a motor neuron survival factor in vitro. Proc Natl Acad Sci USA. 2005;102:16421-16425.
6. WittmannW,McLennan IS. The male bias in the number of purkinje cells and the size of the murine cerebellum may require Müllerian inhibiting substance/anti-Müllerian hormone. J Neuroendocrinol. 2011;23:831-838.
7. Wittmann W, McLennan IS. Anti-Mullerian hormone may regulate the number of calbindin-positive neurons in the sexually dimorphic nucleus of the preoptic area of male mice. Biol Sex Differ. 2013;4:18.
8. Catlin EA, Tonnu VC, Ebb RG, et al. Müllerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung. Endocrinology. 1997;138:790-796.
9. Weenen C, Laven JS, Von Bergh AR, et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10: 77-83.
10. Durlinger AL, Kramer P, Karels B, et al. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology. 1999;140:5789-5796.
11. Visser JA, Durlinger AL, Peters IJ, et al. Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Müllerian hormone null mice. Endocrinology. 2007;148:2301-2308.
12. Dewailly D, AndersenCY,Balen A, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20:370-385.
13. Visser JA, Schipper I, Laven JS, Themmen AP. Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol. 2012;8:331-341.
14. McLennan IS, Pankhurst MW. Anti-Müllerian hormone is a gonadal cytokine with two circulating forms and cryptic actions. J Endocrinol. 2015;226:R45-R57.
15. Constam DB. Regulation of TGFβ and related signals by precursor processing. Semin Cell Dev Biol. 2014;32:85-97.
16. Pankhurst MW, McLennan IS. Human blood contains both the uncleaved precursor of anti-Mullerian hormone and a complex of the NH2-and COOH-terminal peptides. Am J Physiol Endocrinol Metab. 2013;305:E1241-E1247.
17. Nachtigal MW, Ingraham HA. Bioactivation of Müllerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoprotease. Proc Natl Acad Sci USA. 1996;93:7711-7716.
18. Pepinsky RB, Sinclair LK, Chow EP, et al. Proteolytic processing of mullerian inhibiting substance produces a transforming growth factor- β-like fragment. J Biol Chem. 1988;263:18961-18964.
19. Campbell BK, Clinton M, Webb R. The role of anti-Müllerian hormone( AMH)during follicle development in a monovulatory species (sheep). Endocrinology. 2012;153:4533-4543.
20. Picard JY, Josso N. Purification of testicular anti-Müllerian hormone allowing direct visualization of the pure glycoprotein and determination of yield and purification factor. Mol Cell Endocrinol. 1984;34:23-29.
21. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med. 2008;264:224-236.
22. Shiga A, Nozaki H, Yokoseki A, et al. Cerebral small-vessel disease protein HTRA1 controls the amount of TGF-β1 via cleavage of proTGF-β1. Hum Mol Genet. 2011;20:1800-1810.
23. di Clemente N, Ghaffari S, Pepinsky RB, et al. A quantitative and interspecific test for biological activity of anti-müllerian hormone: the fetal ovary aromatase assay. Development. 1992;114:721-727.
24. MacLaughlin DT, Hudson PL, Graciano AL, et al. Mullerian duct regression and antiproliferative bioactivities of Mullerian inhibiting substance reside in its carboxy-terminal domain. Endocrinology. 1992;131:291-296.
25. Mishina Y, Rey R, Finegold MJ, et al. Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev. 1996;10:2577-2587.
26. Hempstead BL. Deciphering proneurotrophin actions. Handb Exp Pharmacol. 2014;220:17-32.
27. Nykjaer A, Lee R, Teng KK, Jansen P, et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature. 2004;427:843-848.
28. Wang J, Dicken C, Lustbader JW, Tortoriello DV. Evidence for a Müllerian-inhibiting substance autocrine/paracrine system in adult human endometrium. Fertil Steril. 2009;91:1195-1203.
29. Caroni P. Overexpression of growth-associated proteins in the neurons of adult transgenic mice. J Neurosci Methods. 1997;71:3-9.
30. McLennan IS, Taylor-Jeffs J. The use of sodium lamps to brightly illuminate mouse houses during their dark phases. Lab Anim. 2004; 38:384-392.
31. Chapman ME, Hu L, Plato CF, Kohan DE. Bioimpedance spectroscopy for the estimation of body fluid volumes in mice. Am J Physiol Renal Physiol. 2010;299:F280-F283.
32. Aksglaede L, Sørensen K, Boas M, et al. Changes in anti-Müllerian hormone(AMH)throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab. 2010;95:5357-5364.
33. Al-Attar L, Noël K, Dutertre M, et al. Hormonal and cellular regulation of Sertoli cell anti-Müllerian hormone production in the postnatal mouse. J Clin Invest. 1997;100:1335-1343.
34. Hill SA. Pharmacokinetics of drug infusions. Continuing Education in Anaesthesia. Crit Care Pain. 2004;4:76-80.
35. Werle M, Bernkop-Schnürch A. Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids. 2006;30:351-367.
36. Bungum L, Jacobsson AK, Rosén F, et al. Circadian variation in concentration of anti-Müllerian hormone in regularly menstruating females: relation to age, gonadotrophin and sex steroid levels. Hum Reprod. 2011;26:678-684.
37. Chong YH, Pankhurst MW, McLennan IS. The daily profiles of circulating AMH and INSL3 in men are distinct from the other testicular hormones, inhibin B and testosterone. PLoS One. 2015; 10:e0133637.
38. Imhoff FM, Yang D, Mathew SF, et al. The type 2 anti-Müllerian hormone receptor has splice variants that are dominant-negative inhibitors. FEBS Lett. 2013;587:1749-1753.
39. Josso N, Belville C, di Clemente N, Picard JY. AMH and AMH receptor defects in persistent Müllerian duct syndrome. Hum Reprod Update. 2005;11:351-356.
40. SriramanV,NiuE,MatiasJR,etal.Müllerianinhibitingsubstanceinhibits testosterone synthesis in adult rats. J Androl. 2001;22:750-758.
41. Griesinger G, Dafopoulos K, Buendgen N, et al. Elimination half-life of anti-Müllerian hormone. J Clin Endocrinol Metab. 2012;97: 2160-2163.
42. Vigier B, Tran D, du Mesnil du Buisson F, Heyman Y, Josso N. Use of monoclonal antibody techniques to study the ontogeny of bovine anti-Müllerian hormone. J Reprod Fertil. 1983;69:207-214.
43. Lin JH. Species similarities and differences in pharmacokinetics. Drug Metab Dispos. 1995;23:1008-1021.
44. Pankhurst MW, McLennan IS. A specific immunoassay for proAMH, the uncleaved proprotein precursor of anti-Müllerian hormone. Mol Cell Endocrinol. 2015;419:165-171.